AIPM 2023 is for statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine; foster collaboration among industry, academia, regulatory agencies, and professional associations; and propose recommendations for proper implementation of AI in promoting public health.
pharmaceutical medicine
ASA to Cosponsor AI in Clinical Drug Development Symposium in May
The Pfizer/ASA/Columbia University Symposium on Risks and Opportunities of AI in Clinical Drug Development aims to advance the use of artificial intelligence (AI) in drug development and deployment.